IntelGenx Technologies (IGX) News Today C$0.58 +0.01 (+1.75%) As of 10/6/2021 Add Compare Share Share Headlines Stock AnalysisBuy This Stock IGX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period IntelGenx Technologies Corp.: IntelGenx Obtains Court-Approval of a Sale and Investment Solicitation ProcessMay 28, 2024 | finanznachrichten.deIntelGenx Technologies Corp.: IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic AlternativesMay 17, 2024 | finanznachrichten.deClosing Bell: Intelgenx Technologies Corp up on Thursday (IGX)May 17, 2024 | theglobeandmail.comIntelGenx: Q1 Earnings SnapshotMay 15, 2024 | washingtonpost.comStocks in play: IntelGenx Corp.April 8, 2024 | ca.finance.yahoo.comIntelGenx Technologies Corp.: IntelGenx Updates Status of Buprenorphine Buccal Film ANDAApril 5, 2024 | finanznachrichten.deIntelGenx Launches Preferred Share Regulation A OfferingFebruary 20, 2024 | uk.finance.yahoo.comNVIDIA partners with Amgen to build generative AI models for drug discoveryJanuary 11, 2024 | msn.comCHANGES TO BOARD OF DIRECTORS OF GEEKCOJanuary 2, 2024 | finance.yahoo.comIntelGenx Technologies Corp.: IntelGenx Announces New Animal Health Partnership; Enters into Development and License Agreements for VetaFilmDecember 18, 2023 | finanznachrichten.deIntelGenx Announces Closing of Previously Announced Subsequent Non-Brokered Private Placement With atai Life Sciences for Aggregate Gross Proceeds of US$750,000December 5, 2023 | finance.yahoo.comIntelGenx Announces Changes to its Board of DirectorsDecember 4, 2023 | finance.yahoo.comIntelGenx Technologies Corp.: IntelGenx Announces Shareholder Approval of Financing TransactionsNovember 29, 2023 | finanznachrichten.deClosing Bell: Intelgenx Technologies Corp up on Monday (IGX)November 13, 2023 | theglobeandmail.comIntelGenx Technologies Corp.: IntelGenx Reports Third Quarter 2023 Financial ResultsNovember 10, 2023 | finanznachrichten.deClosing Bell: Intelgenx Technologies Corp up on Tuesday (IGX)November 7, 2023 | theglobeandmail.comIntelGenx to Report Third Quarter 2023 Financial Results on November 9, 2023 – Conference Call to FollowNovember 2, 2023 | finance.yahoo.comClosing Bell: Intelgenx Technologies Corp flat on Friday (IGX)October 21, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp down on Thursday (IGX)October 13, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp flat on Thursday (IGX)October 7, 2023 | theglobeandmail.comIntelGenx Provides Regulatory Update for Xiromed-Partnered Development Candidate, Buprenorphine Buccal FilmSeptember 19, 2023 | finance.yahoo.comIntelGenx Technologies (IGXT) Price Target Increased by 8.03% to 0.79August 2, 2023 | msn.comIntelGenx Technologies Corp.: IntelGenx Announces a Change to its Board of DirectorsJuly 25, 2023 | finanznachrichten.deIntelGenx Provides Update on Research Collaboration Evaluating Montelukast VersaFilm® for the Treatment of Parkinson’s DiseaseJuly 25, 2023 | finance.yahoo.comIntelGenx Unveils Short-Term Commercial ObjectivesMay 31, 2023 | finance.yahoo.com8-K: IntelGenx Technologies Corp.May 11, 2023 | marketwatch.comIntelGenx Extends Period to Exercise Certain WarrantsApril 27, 2023 | finance.yahoo.comIntelGenx Announces Receipt of Complete Response Letter from the FDA for Xiromed-Partnered Buprenorphine Buccal FilmApril 27, 2023 | finance.yahoo.comClosing Bell: Intelgenx Technologies Corp up on Wednesday (IGX)April 20, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp down on Monday (IGX)April 17, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp up on Friday (IGX)April 15, 2023 | theglobeandmail.comIntelGenx Announces Organizational Changes to Support Global Growth StrategyApril 13, 2023 | finance.yahoo.comClosing Bell: Intelgenx Technologies Corp WT flat on Thursday (IGX-WT)April 9, 2023 | theglobeandmail.comIntelGenx Reports Fourth Quarter and Full-Year 2022 Financial ResultsMarch 29, 2023 | finance.yahoo.comIntelGenx Revises Fourth Quarter and Full Year 2022 Financial Results Reporting and Conference Call Date to March 29, 2023March 24, 2023 | finance.yahoo.comIntelGenx to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 – Conference Call to FollowMarch 23, 2023 | finance.yahoo.comIntelGenx to Participate in the 35th Annual Roth ConferenceMarch 9, 2023 | finance.yahoo.comCORRECTION – IntelGenx to Participate in the 35th Annual Roth ConferenceMarch 9, 2023 | finance.yahoo.comIntelGenx Technologies Corp. (IGX.TO)February 16, 2023 | ca.finance.yahoo.comIIROC Trading Halt - IGX.WTFebruary 13, 2023 | finance.yahoo.comIntelgenx Technologies, Cybin Among Top Psychedelic Movers Of TodayJanuary 14, 2023 | msn.comIntelGenx Receives Fourth and Final Loan Tranche from ataiJanuary 9, 2023 | finance.yahoo.comIntelGenx Reports Third Quarter 2022 Financial ResultsNovember 10, 2022 | finance.yahoo.comIntelGenx Enters into Feasibility & Development Agreement For CBD-Infused VetaFilm™November 9, 2022 | finance.yahoo.comIntelGenx Announces Issuance of New U.S. Patent Covering VersaFilm® TechnologyOctober 20, 2022 | finance.yahoo.comIntelGenx Submits Response to CRL from FDA for RIZAPORT® VersaFilm®October 18, 2022 | finance.yahoo.comNVIDIA Launches IGX Edge AI Computing Platform for Safe, Secure Autonomous SystemsSeptember 20, 2022 | it.tmcnet.comIntelGenx Announces Enrollment Reaches Halfway Mark in ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s DiseaseSeptember 8, 2022 | finance.yahoo.comIntelGenx Reports Second Quarter 2022 Financial ResultsAugust 11, 2022 | finance.yahoo.comStocks in play: IntelGenx Technologies Corp.August 4, 2022 | ca.finance.yahoo.com Get IntelGenx Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IGX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IGX Media Mentions By Week IGX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IGX News Sentiment▼0.000.93▲Average Medical News Sentiment IGX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IGX Articles This Week▼00▲IGX Articles Average Week Get the Latest News and Ratings for IGX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for IntelGenx Technologies and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies First Mining Gold News Nutrien News Canaccord Genuity Group News Vitalhub News Ensign Energy Services News Fennec Pharmaceuticals News Theratechnologies News Helix BioPharma News Medicenna Therapeutics News Covalon Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:IGX) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IntelGenx Technologies Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share IntelGenx Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
